Figure 7 of
El-Remessy, Mol Vis 2000;
6:243-251.Figure 7 of
El-Remessy, Mol Vis 2000;
6:243-251.
Figure 7. Effect of laminin pretreatment on IRBP gene expression in forskolin treated WERI-Rb1 cells: RNase protection analysis
A: A typical RNase protection analysis of IRBP and b-actin gene expression. C, control (untreated); LN, pretreatment with laminin for 1, 2, or 3 days then treated with forskolin (10 mM) and IBMX (0.5 mM) for 8 h. B: Relative IRBP/b-actin mRNA normalized to its corresponding control. Data are means±S.D. for each treatment group, N=3 per group. Asterisk indicates level of statistical significance: * for p<0.05.
